Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial

BACKGROUND: Minimally invasive thrombolytic evacuation of intracerebral hematoma is being investigated in the ongoing phase III clinical trial of Minimally Invasive Surgery plus recombinant Tissue plasminogen activator for Intracerebral hemorrhage Evacuation (MISTIE III). OBJECTIVE: To assess the ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurosurgery
Hauptverfasser: Fam, Maged D, Hanley, Daniel, Stadnik, Agnieszka, Zeineddine, Hussein A, Girard, Romuald, Jesselson, Michael, Cao, Ying, Money, Lynn, McBee, Nichol, Bistran-Hall, Amanda J, Mould, W Andrew, Lane, Karen, Camarata, Paul J, Zuccarello, Mario, Awad, Issam A
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2017
Schlagworte:
Research—Human—Clinical Studies
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6257031/
https://ncbi.nlm.nih.gov/pubmed/28402516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuros/nyx123
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge